Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-24-043292

Options or other derivatives

  • Chief Financial Officer acquired 145,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shawah Robert G. Chief Financial Officer 2024-02-23 Grant or award · Stock Option +145,000 145,000 D
Loading xslF345X05/tm2411025-3_4seq1.xml…